000 | 01875 a2200541 4500 | ||
---|---|---|---|
005 | 20250515235306.0 | ||
264 | 0 | _c20101207 | |
008 | 201012s 0 0 eng d | ||
022 | _a1521-0111 | ||
024 | 7 |
_a10.1124/mol.110.066076 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEich, Marcus | |
245 | 0 | 0 |
_aNijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide. _h[electronic resource] |
260 |
_bMolecular pharmacology _cNov 2010 |
||
300 |
_a943-51 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xpharmacology |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aCaspase 7 _xmetabolism |
650 | 0 | 4 |
_aCell Cycle Proteins _xgenetics |
650 | 0 | 4 | _aCell Line, Transformed |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDNA Methylation |
650 | 0 | 4 |
_aDacarbazine _xanalogs & derivatives |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 |
_aFibroblasts _xdrug effects |
650 | 0 | 4 |
_aGuanine _xanalogs & derivatives |
650 | 0 | 4 | _aHomozygote |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMelanoma |
650 | 0 | 4 |
_aMethylnitronitrosoguanidine _xpharmacology |
650 | 0 | 4 |
_aMutagens _xpharmacology |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aNecrosis |
650 | 0 | 4 |
_aNijmegen Breakage Syndrome _xpathology |
650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
650 | 0 | 4 | _aPoly (ADP-Ribose) Polymerase-1 |
650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerases _xmetabolism |
650 | 0 | 4 | _aTemozolomide |
650 | 0 | 4 | _aUveal Neoplasms |
650 | 0 | 4 | _aUveal Melanoma |
700 | 1 | _aRoos, Wynand P | |
700 | 1 | _aDianov, Grigory L | |
700 | 1 | _aDigweed, Martin | |
700 | 1 | _aKaina, Bernd | |
773 | 0 |
_tMolecular pharmacology _gvol. 78 _gno. 5 _gp. 943-51 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1124/mol.110.066076 _zAvailable from publisher's website |
999 |
_c20064778 _d20064778 |